Tag: crescita therapeutics
November 6, 2019
Crescita Gets FDA Approval for Enhanced Formulation of Pliaglis
The company received approval from the US Food and Drug Administration for the enhanced formulation of its topical treatment Pliaglis. October 28, 2019
Sundial Announces Cannabis and Hemp Topicals Partnership
Sundial Growers (NASDAQ:SNDL) and Crescita Therapeutics (TSX:CTX,OTC:CRRTF) announced an agreement on Monday (October 28) that gives Sundial the rights to Crescita’s skin...
July 9, 2019
3 Top Pharma Stocks on the TSX Year-to-Date
At the halfway mark of the year, it's time to look back on the top performing pharma stocks on the...
June 6, 2019
VIDEO — US vs. Canada Healthcare Systems: Is One Better?
INN asked four company CEOs their thoughts on the US and Canadian healthcare systems and whether one is better than...
May 16, 2019
VIDEO Round-Up BBHIC 2019
BBHIC is over for another year. In case you missed it, here's a compilation of all INN's video interviews from...
May 15, 2019
VIDEO — Crescita Therapeutics CEO: Advancing Pliaglis in Europe
CEO Serge Verreault says a new partnership with Cantabria Labs will bring Pliaglis to Italy, Portugal, France and Spain. May 15, 2019